Announcement on Prednisolone Tablets Passing Generic Drug Consistency Evaluation
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Prednisolone Tablets Passing Generic Drug Consistency Evaluation
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-prednisolone-tablets-passing-generic-drug-consistency-evaluation
Release
Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix
Earlier from Shanghai Pharmaceuticals
- Announcement on Digoxin Tablets Passing Generic Drug Consistency Evaluation
- Announcement on Proposed Issuance of Debt Financing Products
- Announcement on Convening the 2025 Annual Performance Briefing
- Announcement on Completion of Generic Drug Consistency Evaluation for Cefazolin Sodium for Injection
- Announcement on Subsidiary Obtaining Philippine Drug Registration Certificate for Pregabalin Capsules
Later from Shanghai Pharmaceuticals
- Announcement on Progress in Proposed Public Listing and Transfer of 30% Equity in Sino-American Shanghai Squibb Pharmaceuticals Co., Ltd.
- Report for Q1 2026
- Announcement on Obtainment of Drug Registration Certificate for Rivaroxaban Tablets in Thailand
- Announcement on the Interim Dividend Distribution Arrangement in 2026
- Announcement on Subsidiary Becoming the Marketing Authorization Holder of Trazodone Hydrochloride Tablets
Follow Shanghai Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Pharmaceuticals